Can the Gene Expression Profile of Patients with Acute Myeloid Leukemia Predict Complete Remission Following Induction Therapy?

Recent advances in sequencing technologies and genomics have led to the development of several targeted therapies such as BCL2 and Bromodomain and extra-terminal (BET) protein inhibitors for a more personalized treatment of patients with acute myeloid leukemia (AML), yet the majority of patients sti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Sosa, Santiago, Rodríguez-Medina, Carlos, Stuckey, Ruth, Florido, Yanira, Santana, Guillermo, González Martín, Jesús María, Cruz-Cruz, Naylén, Torres-Ochando, Melissa, Fernández, Rosa, Sánchez-Farías, Nuria, Cionfrini, Antonia, Labarta, Teresa Molero, Gomez-Casares, María Teresa, Bilbao-Sieyro, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899374/
https://www.ncbi.nlm.nih.gov/pubmed/35281876
http://dx.doi.org/10.7150/jca.57457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899374/
https://www.ncbi.nlm.nih.gov/pubmed/35281876
http://dx.doi.org/10.7150/jca.57457

Ejemplares similares